cytogen corp said its will expand clinical trials its cancer imaging technology said new studies were anticipated mid year said first phase human testing begain october technology uses monocloncal antibody tagged with radioisotope diagnose colorectal cancer and several cancer types said preliminary studies revealed antibody combination was well tolerated patients studied reuter 